What Happened?
Cambridge, MA-based Gemini Therapeutics Promoted Scott Lauder as Chief Technology Officer
Date of management change: May 30, 2018
Cambridge, MA-based Gemini Therapeutics Promoted Scott Lauder as Chief Technology Officer
Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. Our therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world, we are developing a series of first-in-class therapeutics.
Scott Lauder is Chief Technology Officer at Gemini Therapeutics. Previously, Scott held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Pfeifel Eyal, Fries Frank, Hale Richard, Kline Carol, Jayaraman Vijay, Farazi Payam, Crowell Cameron, Wilson Kelli, Hotchkiss Steve, Fazio Allen, Curcio Gene
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.